Tag: psychopharmacology

High-dose Clozapine Withdrawal: A Case Report and Timeline of a Single Potential Withdrawal Seizure

High-dose Clozapine Withdrawal: A Case Report and Timeline of a Single Potential Withdrawal Seizure

| July 1, 2019

by Megan K. Skelly, PharmD, BCPS; Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP; and Claudia Lee, MD Drs. Skelly, Demler, and Lee are with the State University at Buffalo (SUNY) School of Pharmacy and Pharmaceutical Sciences, Department of Pharmacy Practice in Buffalo, New York and Drs. Demler and Lee are also with New York […]

Continue Reading

The Dopamine Dilemma—Part II:  Could Stimulants Cause Tolerance, Dependence, and Paradoxical Decompensation?

The Dopamine Dilemma—Part II: Could Stimulants Cause Tolerance, Dependence, and Paradoxical Decompensation?

| January 21, 2011 | 0 Comments

by Jason Yanofski, MD Dr. Yanofski is a forensic and clinical psychiatrist at the Minor Traumatic Brain Injury (MTBI) Clinic at US Army Garrison, Bamberg, Germany; Dr. Yanofski was working at the San Quentin State Prison, San Quentin, California, during preparation of this manuscript. Dr. Yanofski trained at Johns Hopkins University in Baltimore, Maryland; University […]

Continue Reading

Revisiting the Clinical Utility of Cytochrome p450 in Practice

| November 8, 2007 | 0 Comments

by Andrew A. Nierenberg, MD; and Steven D. Targum, MD Dr. Targum is on the editorial board of Psychiatry 2007. Presently, he is Chief Medical Officer at Brain Cells Inc., an executive-in-residence at Oxford BioScience Partners, and a consultant in psychiatry at the Massachusetts General Hospital, Boston, Massachusetts; and Dr. Nierenberg is Director, Bipolar Trials […]

Continue Reading